Table 5.
PET, V B | MRI | Relative difference (%), V B | p, V B | |
ESVs, mL | 103 ± 34 | 86 ± 28 | 21.3 ± 20.6 | 0.004 |
EDVs, mL | 219 ± 53 | 232 ± 47 | − 5.8 ± 11.3 | 0.137 |
SVs, mL | 116 ± 24 | 146 ± 26 | − 20.5 ± 11.6 | < 0.001 |
LVEFs, % | 54 ± 7 | 64 ± 2 | − 15.5 ± 7.6 | < 0.001 |
ESVv, mL | 92 ± 36 | 86 ± 28 | 7.6 ± 20.6 | 0.221 |
EDVv, mL | 264 ± 61 | 232 ± 47 | 14.1 ± 13.6 | 0.005 |
SVv, mL | 172 ± 37 | 146 ± 26 | 17.9 ± 17.6 | 0.004 |
LVEFv, % | 66 ± 8 | 64 ± 2 | 3.3 ± 9.0 | 0.203 |
LVEFc, % | 74 ± 8 | 64 ± 2 | 15.8 ± 9.1 | < 0.001 |
PET, FP | MRI | Relative difference (%), FP | p, FP | |
ESVs, mL | 100 ± 36 | 86 ± 28 | 16.9 ± 13.8 | 0.003 |
EDVs, mL | 193 ± 49 | 232 ± 47 | − 16.9 ± 10.4 | < 0.001 |
SVs, mL | 94 ± 23 | 146 ± 26 | − 35.7 ± 13.8 | < 0.001 |
LVEFs, % | 49 ± 8 | 64 ± 2 | − 23.0 ± 9.0 | < 0.001 |
ESVv, mL | 98 ± 43 | 86 ± 28 | 13.6 ± 21.2 | 0.076 |
EDVv, mL | 236 ± 56 | 232 ± 47 | 1.5 ± 12.1 | 0.652 |
SVv, mL | 137 ± 34 | 146 ± 26 | − 5.5 ± 19.9 | 0.307 |
LVEFv, % | 59 ± 10 | 64 ± 2 | − 7.2 ± 12.5 | 0.074 |
LVEFc, % | 70 ± 9 | 64 ± 2 | 9.8 ± 11.9 | 0.015 |